Prot#GS-US-418-4279: A Randomized, Double-blind, Placebo-controlled Phase 2 Study to Evaluate the Testicular Safety of Filgotinib in Adult Males with Moderately to Severely Active Ulcerative Colitis

Project: Research project

Project Details

StatusFinished
Effective start/end date10/12/18 → 10/12/21

Funding

  • PRA Health Sciences (GS-US-418-4279 // GS-US-418-4279)
  • Gilead Sciences, Inc (GS-US-418-4279 // GS-US-418-4279)